BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lu YL, Li GL, Huang HL, Zhong J, Dai LC. Peroxisome proliferator-activated receptor-γ 34C>G polymorphism and colorectal cancer risk: A meta-analysis. World J Gastroenterol 2010; 16(17): 2170-2175 [PMID: 20440859 DOI: 10.3748/wjg.v16.i17.2170]
URL: https://www.wjgnet.com/1007-9327/full/v16/i17/2170.htm
Number Citing Articles
1
Xuemin Liang, Xiaohua Fan, Kanglian Tan, Li Zhang, Lisi Jian, Linchong Yu. Peroxisome proliferators-activated receptor gamma polymorphisms and colorectal cancer riskJournal of Cancer Research and Therapeutics 2018; 14(Suppl 2): S306 doi: 10.4103/0973-1482.235346
2
Rong Xie, Shaobo Tang, Yanna Yang. Associations of peroxisome proliferator-activated receptor-γ Pro12Ala polymorphism with non-alcoholic fatty liver disease: A meta-analysisJournal of Diabetes and its Complications 2022; 36(10): 108261 doi: 10.1016/j.jdiacomp.2022.108261
3
Xiyong Bai. Effect of Proliferator-Activated Receptor-γ Pro12Ala Polymorphism on Colorectal Cancer Risk: A Meta-AnalysisMedical Science Monitor 2015; 21: 1611 doi: 10.12659/MSM.892849
4
Jun Wang, Xufeng Guo, Pengbo Wu, Jia Song, Chuncui Ye, Shijie Yu, Jixiang Zhang, Weiguo Dong. Association between the Pro12Ala polymorphism of PPAR-γ gene and the non-alcoholic fatty liver disease: A meta-analysisGene 2013; 528(2): 328 doi: 10.1016/j.gene.2013.07.014
5
Hassan R. Dhaini, Zeina Daher. Genetic polymorphisms of PPAR genes and human cancers: evidence for gene–environment interactionsJournal of Environmental Science and Health, Part C 2019; 37(3): 146 doi: 10.1080/10590501.2019.1593011
6
Valerio Pazienza, Manlio Vinciguerra, Gianluigi Mazzoccoli. PPARs Signaling and Cancer in the Gastrointestinal SystemPPAR Research 2012; 2012: 1 doi: 10.1155/2012/560846
7
Mingqi Li, Qi You, Xishan Wang. Association Between Polymorphism of the Tumor Necrosis Factor Alpha-308 Gene Promoter and Colon Cancer in the Chinese PopulationGenetic Testing and Molecular Biomarkers 2011; 15(11): 743 doi: 10.1089/gtmb.2011.0068
8
Yujun Wang, Chibo Liu. Quantitative evaluation of common polymorphism (rs1801282) in the PPARγ2 gene and hypertension susceptibilityGene 2012; 502(2): 159 doi: 10.1016/j.gene.2012.04.035
9
Mujeeb Zafar Banday, Aga Syed Sameer, Saniya Nissar. Genetic Polymorphism and cancer susceptibility2021; : 119 doi: 10.1007/978-981-33-6699-2_5
10
Meena K. Sakharkar, Babita Shashni, Karun Sharma, Sarinder K. Dhillon, Prabhakar R. Ranjekar, Kishore R. Sakharkar. Therapeutic Implications of Targeting Energy Metabolism in Breast CancerPPAR Research 2013; 2013: 1 doi: 10.1155/2013/109285
11
Jing Zhao, Zheng Zhi, Guangyao Song, Juan Wang, Chao Wang, Huijuan Ma, Xian Yu, Aixia Sui, Hongtao Zhang. Peroxisome Proliferator-Activated Receptor-Gamma Pro12Ala Polymorphism Could be a Risk Factor for Gastric CancerAsian Pacific Journal of Cancer Prevention 2015; 16(6): 2333 doi: 10.7314/APJCP.2015.16.6.2333
12
E. Theodoratou, Z. Montazeri, S. Hawken, G. C. Allum, J. Gong, V. Tait, I. Kirac, M. Tazari, S. M. Farrington, A. Demarsh, L. Zgaga, D. Landry, H. E. Benson, S. H. Read, I. Rudan, A. Tenesa, M. G. Dunlop, H. Campbell, J. Little. Systematic Meta-Analyses and Field Synopsis of Genetic Association Studies in Colorectal CancerJNCI Journal of the National Cancer Institute 2012; 104(19): 1433 doi: 10.1093/jnci/djs369